FAQ/Help |
Calendar |
Search |
Today's Posts |
|
05-15-2015, 08:06 AM | #1 | ||
|
|||
Member
|
http://ir.amarantus.com/company-news/detail/1992
Amarantus Announces Successful Delivery and Distribution of MANF in Preclinical Model to Brain Areas Involved in Parkinson's Disease |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Amarantus BioScience Announces Positive Efficacy Data for MANF in a Nigral Delivery N | Parkinson's Disease | |||
Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neuroresto | Parkinson's Disease | |||
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease | Parkinson's Disease | |||
VP025 Provides a Neuroprotective Effect in Preclinical Model of Parkinson's Disease | Parkinson's Disease |